Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Frequency Completes Human Progenitor Cell Activation Study to Restore Hearing

Frequency Therapeutics successfully completed a first-in-human study evaluating its lead Progenitor Cell Activation (PCA™) candidate FX-322, which is in ...

Forward this item to a colleague:


(Separate multiple addresses by commas)